Sponsor

Centre Hospitalier Universitaire D'Angers

France 4 Rue Larrey, 49100 Angers, France

About the sponsor

Clinical research includes acute myeloid leukemia, chronic lymphocytic leukemia, follicular lymphoma, Hodgkin lymphoma, and myeloma, with attention to treatment strategies, survival outcomes, and supportive care in hematologic malignancies.

Acute myeloid leukemia
Chronic lymphocytic leukemia
Follicular lymphoma
Hodgkin lymphoma
Myeloma

Research activity also extends to allogeneic transplantation and graft-versus-host disease prevention in patients with high-risk blood disorders.

About Specializations

Centre Hospitalier Universitaire D'Angers runs clinical trials in conditions such as Follicular lymphoma, Plasma cell myeloma, Oesophageal squamous cell carcinoma, Cholangiocarcinoma, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Quick filters

7 clinical trials

Follicular lymphoma+7

Recruiting

Study on Safe Skin Test Concentrations for Biotherapy Allergies in Patients with Cancer Using Atezolizumab, Daratumumab, and Nivolumab

Registered drugNo placebo

Study on Safe Skin Test Concentrations for Biotherapy Allergies in Patients with Cancer Using Atezolizumab, Daratumumab, and Nivolumab

Registered drugNo placebo

France

Participants:18–64 years · 65+ years · Healthy volunteers
Substances:Atezolizumab
Sponsor:Centre Hospitalier Universitaire D'Angers

Contact Research Centre

Joint stabilisation

Recruiting

Study Comparing Rivaroxaban and Drug Combination for Preventing Blood Clots in Patients with Lower Limb Injuries Requiring Immobilization

Registered drugNo placebo

Study Comparing Rivaroxaban and Drug Combination for Preventing Blood Clots in Patients with Lower Limb Injuries Requiring Immobilization

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Dalteparin Sodium
Sponsor:Centre Hospitalier Universitaire D'Angers

Contact Research Centre

Craniopharyngioma

Not yet recruiting

A study to evaluate the effectiveness of semaglutide for treating obesity caused by craniopharyngioma in children aged 12 to 17 years.

Registered drug

A study to evaluate the effectiveness of semaglutide for treating obesity caused by craniopharyngioma in children aged 12 to 17 years.

Registered drug

France

Participants:0–17 years
Substances:Semaglutide
Sponsor:Centre Hospitalier Universitaire D'Angers

Contact Research Centre

Hereditary optic atrophy

Not yet recruiting

A study to evaluate the effectiveness of nicotinamide in patients with Leber's hereditary optic neuropathy who have experienced vision loss within the last 18 months

Registered drugNo placebo